Dilip Jayasimhan1, Simon Foster2, Catherina L Chang2, Robert J Hancox2,3. 1. Respiratory Research Unit, Department of Respiratory Medicine, Waikato Hospital, Pembroke Street, Hamilton, 3204, New Zealand. d.jayasimhan@gmail.com. 2. Respiratory Research Unit, Department of Respiratory Medicine, Waikato Hospital, Pembroke Street, Hamilton, 3204, New Zealand. 3. Department of Preventative and Social Medicine, Otago Medical School, University of Otago, Dunedin, New Zealand.
Abstract
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a leading cause of morbidity and mortality in the intensive care unit. Biochemical markers of cardiac dysfunction are associated with high mortality in many respiratory conditions. The aim of this systematic review is to examine the link between elevated biomarkers of cardiac dysfunction in ARDS and mortality. METHODS: A systematic review of MEDLINE, EMBASE, Web of Science and CENTRAL databases was performed. We included studies of adult intensive care patients with ARDS that reported the risk of death in relation to a measured biomarker of cardiac dysfunction. The primary outcome of interest was mortality up to 60 days. A random-effects model was used for pooled estimates. Funnel-plot inspection was done to evaluate publication bias; Cochrane chi-square tests and I2 tests were used to assess heterogeneity. RESULTS: Twenty-two studies were included in the systematic review and 18 in the meta-analysis. Biomarkers of cardiac stretch included NT-ProBNP (nine studies) and BNP (six studies). Biomarkers of cardiac injury included Troponin-T (two studies), Troponin-I (one study) and High-Sensitivity-Troponin-I (three studies). Three studies assessed multiple cardiac biomarkers. High levels of NT-proBNP and BNP were associated with a higher risk of death up to 60 days (unadjusted OR 8.98; CI 4.15-19.43; p<0.00001). This association persisted after adjustment for age and illness severity. Biomarkers of cardiac injury were also associated with higher mortality, but this association was not statistically significant (unadjusted OR 2.21; CI 0.94-5.16; p= 0.07). CONCLUSION: Biomarkers of cardiac stretch are associated with increased mortality in ARDS.
BACKGROUND:Acute respiratory distress syndrome (ARDS) is a leading cause of morbidity and mortality in the intensive care unit. Biochemical markers of cardiac dysfunction are associated with high mortality in many respiratory conditions. The aim of this systematic review is to examine the link between elevated biomarkers of cardiac dysfunction in ARDS and mortality. METHODS: A systematic review of MEDLINE, EMBASE, Web of Science and CENTRAL databases was performed. We included studies of adult intensive care patients with ARDS that reported the risk of death in relation to a measured biomarker of cardiac dysfunction. The primary outcome of interest was mortality up to 60 days. A random-effects model was used for pooled estimates. Funnel-plot inspection was done to evaluate publication bias; Cochrane chi-square tests and I2 tests were used to assess heterogeneity. RESULTS: Twenty-two studies were included in the systematic review and 18 in the meta-analysis. Biomarkers of cardiac stretch included NT-ProBNP (nine studies) and BNP (six studies). Biomarkers of cardiac injury included Troponin-T (two studies), Troponin-I (one study) and High-Sensitivity-Troponin-I (three studies). Three studies assessed multiple cardiac biomarkers. High levels of NT-proBNP and BNP were associated with a higher risk of death up to 60 days (unadjusted OR 8.98; CI 4.15-19.43; p<0.00001). This association persisted after adjustment for age and illness severity. Biomarkers of cardiac injury were also associated with higher mortality, but this association was not statistically significant (unadjusted OR 2.21; CI 0.94-5.16; p= 0.07). CONCLUSION: Biomarkers of cardiac stretch are associated with increased mortality in ARDS.
Authors: G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg Journal: Am J Respir Crit Care Med Date: 1994-03 Impact factor: 21.405
Authors: Martin I MacDonald; Eskandarain Shafuddin; Paul T King; Catherina L Chang; Philip G Bardin; Robert J Hancox Journal: Lancet Respir Med Date: 2016-01-16 Impact factor: 30.700
Authors: Marcelo B P Amato; Maureen O Meade; Arthur S Slutsky; Laurent Brochard; Eduardo L V Costa; David A Schoenfeld; Thomas E Stewart; Matthias Briel; Daniel Talmor; Alain Mercat; Jean-Christophe M Richard; Carlos R R Carvalho; Roy G Brower Journal: N Engl J Med Date: 2015-02-19 Impact factor: 91.245
Authors: Stefan M T Vestjens; Simone M C Spoorenberg; Ger T Rijkers; Jan C Grutters; Jurriën M Ten Berg; Peter G Noordzij; Ewoudt M W Van de Garde; Willem Jan W Bos Journal: Respirology Date: 2017-02-21 Impact factor: 6.424
Authors: Giacomo Bellani; John G Laffey; Tài Pham; Fabiana Madotto; Eddy Fan; Laurent Brochard; Andres Esteban; Luciano Gattinoni; Vesna Bumbasirevic; Lise Piquilloud; Frank van Haren; Anders Larsson; Daniel F McAuley; Philippe R Bauer; Yaseen M Arabi; Marco Ranieri; Massimo Antonelli; Gordon D Rubenfeld; B Taylor Thompson; Hermann Wrigge; Arthur S Slutsky; Antonio Pesenti Journal: Am J Respir Crit Care Med Date: 2017-01-01 Impact factor: 21.405
Authors: Shalini Santhakumaran; Anthony Gordon; A Toby Prevost; Cecilia O'Kane; Daniel F McAuley; Manu Shankar-Hari Journal: Crit Care Date: 2019-05-03 Impact factor: 9.097
Authors: P J McCall; J M Willder; B L Stanley; C-M Messow; J Allan; L Gemmell; A Puxty; D Strachan; C Berry; B G Shelley Journal: Anaesthesia Date: 2022-05-24 Impact factor: 12.893
Authors: Kendal E Harr; Sonya G Gordon; Ryan D Baumwart; Ross Feldgreber; Matthew R Spiro Journal: Vet Clin Pathol Date: 2022-03-20 Impact factor: 1.333